Table 6 Modified Rankin Scale (MRS) among patients group
From: Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery
The patient group (100 stroke patients) | Test | P value | ||||||
|---|---|---|---|---|---|---|---|---|
Carotid atherosclerosis N = 50 | Cardioembolic N = 50 | Total N = 100 | ||||||
No | % | No | % | X2 | ||||
MRS | ||||||||
0 | 5 | 10 | 0 | 0 | 5 | 5 | 77.2 | < 0.001* |
1 | 10 | 20 | 2 | 4 | 12 | 12 | ||
2 | 12 | 24 | 1 | 2 | 13 | 13 | ||
3 | 8 | 16 | 3 | 6 | 11 | 11 | ||
4 | 15 | 30 | 1 | 2 | 16 | 16 | ||
5 | 0 | 0 | 39 | 78 | 39 | 39 | ||
6 | 0 | 0 | 4 | 8 | 4 | 4 | ||